is tirzepatide mounjaro Weight-loss jab trial begins in Manchester Mounjaro (tirzepatide) for the Treatment

No claims are made or implied regarding therapeutic, metabolic, or health-related outcomes

It reduces hunger hormone production, decreases appetite-stimulating signals, and increases dopamine release in reward centers of the brain when you've eaten enough

Exercise can be reintroduced progressively, starting with low-impact cardio and eventually incorporating strength training

This approval was based on results from the Semaglutide Treatment Effect in People with Obesity program (STEP) clinical trials, which evaluated the safety and efficacy of semaglutide as an aid for losing weight in individuals without diabetes

doi: 10.1016/j.freeradbiomed.2023.11.020 183 NiYLiuLJiangFWuMQinY